These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 12110122

  • 1. Matrix metalloproteinases in arthritic disease.
    Murphy G, Knäuper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I.
    Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S39-49. PubMed ID: 12110122
    [Abstract] [Full Text] [Related]

  • 2. Metalloproteinases in Rheumatoid Arthritis: Potential Therapeutic Targets to Improve Current Therapies.
    Itoh Y.
    Prog Mol Biol Transl Sci; 2017; 148():327-338. PubMed ID: 28662826
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biology of metalloproteinases.
    Amălinei C, Căruntu ID, Bălan RA.
    Rom J Morphol Embryol; 2007; 48(4):323-34. PubMed ID: 18060181
    [Abstract] [Full Text] [Related]

  • 7. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.
    Pozgan U, Caglic D, Rozman B, Nagase H, Turk V, Turk B.
    Biol Chem; 2010 May; 391(5):571-9. PubMed ID: 20180636
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Matrix metalloproteinases and their tissue inhibitors].
    Trojanek J.
    Postepy Biochem; 2012 May; 58(3):353-62. PubMed ID: 23373420
    [Abstract] [Full Text] [Related]

  • 11. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G, Lambiri I, Nagel R, Keysser C, Keysser M, Gromnica-Ihle E, Franz J, Burmester GR, Jung K.
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Crystal structures of MMPs in complex with physiological and pharmacological inhibitors.
    Maskos K.
    Biochimie; 2005 Feb; 87(3-4):249-63. PubMed ID: 15781312
    [Abstract] [Full Text] [Related]

  • 14. [Matrix metalloproteinases and cartilage matrix degradation in rheumatoid arthritis].
    Yoshihara Y, Yamada H.
    Clin Calcium; 2007 Apr; 17(4):500-8. PubMed ID: 17404478
    [Abstract] [Full Text] [Related]

  • 15. Differential expression pattern of membrane-type matrix metalloproteinases in rheumatoid arthritis.
    Pap T, Shigeyama Y, Kuchen S, Fernihough JK, Simmen B, Gay RE, Billingham M, Gay S.
    Arthritis Rheum; 2000 Jun; 43(6):1226-32. PubMed ID: 10857781
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
    Visse R, Nagase H.
    Circ Res; 2003 May 02; 92(8):827-39. PubMed ID: 12730128
    [Abstract] [Full Text] [Related]

  • 17. Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-κB ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis.
    van Nieuwenhuijze AE, van de Loo FA, Walgreen B, Bennink M, Helsen M, van den Bersselaar L, Wicks IP, van den Berg WB, Koenders MI.
    Arthritis Res Ther; 2015 Jun 17; 17(1):163. PubMed ID: 26081345
    [Abstract] [Full Text] [Related]

  • 18. Structural basis of the matrix metalloproteinases and their physiological inhibitors, the tissue inhibitors of metalloproteinases.
    Bode W, Maskos K.
    Biol Chem; 2003 Jun 17; 384(6):863-72. PubMed ID: 12887053
    [Abstract] [Full Text] [Related]

  • 19. What are the roles of metalloproteinases in cartilage and bone damage?
    Murphy G, Lee MH.
    Ann Rheum Dis; 2005 Nov 17; 64 Suppl 4(Suppl 4):iv44-7. PubMed ID: 16239386
    [Abstract] [Full Text] [Related]

  • 20. Interactions of T helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells.
    Schurigt U, Pfirschke C, Irmler IM, Hückel M, Gajda M, Janik T, Baumgrass R, Bernhagen J, Bräuer R.
    Arthritis Rheum; 2008 Oct 17; 58(10):3030-40. PubMed ID: 18821693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.